[1]
“Tildrakizumab in patients with metabolic syndrome: A novel approach”, Can Dermatol Today, vol. 2, no. s03, pp. 9–11, Mar. 2021, Accessed: Mar. 19, 2026. [Online]. Available: https://canadiandermatologytoday.com/article/view/2-s03-grewal